August D A
Department of Surgery, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Surg Oncol Clin N Am. 1996 Apr;5(2):399-409.
Pharmacokinetic theory of hepatic arterial infusion chemotherapy predicts that parameters, such as hepatic blood flow, hepatic drug extraction, and extrahepatic drug clearance, may potentially be manipulated to enhance the selectivity of hepatic artery drug administration. In practice, diminution of hepatic blood flow through the use of degradable starch microspheres or gelatin sponge embolization has been accomplished and has improved drug selectivity. Likewise, augmentation of hepatic drug extraction improves the pharmacokinetic advantages of regional chemotherapy for liver tumors. Development of optimal hepatic infusion chemotherapy approaches can be undertaken rationally and in an expeditious fashion by applying pharmacokinetic principles to create innovative treatment regimens and by testing them in preclinical and phase I investigations.
肝动脉灌注化疗的药代动力学理论预测,诸如肝血流量、肝脏药物提取率和肝外药物清除率等参数可能会被调控,以提高肝动脉给药的选择性。在实践中,通过使用可降解淀粉微球或明胶海绵栓塞来减少肝血流量已经实现,并且提高了药物选择性。同样,增强肝脏药物提取率可改善肝肿瘤区域化疗的药代动力学优势。通过应用药代动力学原理来创建创新治疗方案,并在临床前和I期研究中对其进行测试,可以合理且迅速地开展最佳肝灌注化疗方法的研发。